Literature DB >> 6642415

Experimental hyperthyroidism in man: effects on plasma lipoproteins, lipoprotein lipase and hepatic lipase.

P Hansson, S Valdemarsson, P Nilsson-Ehle.   

Abstract

We have studied the effects of triiodothyronine administration (20-40 micrograms three times daily over one week) in six healthy young men, on the activities of lipoprotein lipase and hepatic lipase and on plasma lipoprotein concentrations. Hepatic lipase activity in post-heparin plasma rose by 46 +/- 25% (p less than 0.025), whereas the activity of lipoprotein lipase did not change significantly. Plasma cholesterol concentrations decreased by about 20% (p less than 0.025), whereas there was no change in plasma triglyceride levels. The fall in plasma cholesterol could be accounted for by a reduction of HDL cholesterol (-11%, p less than 0.025) as well as LDL cholesterol (-27%, p less than 0.025). The data emphasize the role of hepatic lipase in the lipoprotein alterations associated with thyroid dysfunction.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6642415     DOI: 10.1055/s-2007-1018751

Source DB:  PubMed          Journal:  Horm Metab Res        ISSN: 0018-5043            Impact factor:   2.936


  12 in total

Review 1.  GC-1: A Thyromimetic With Multiple Therapeutic Applications in Liver Disease.

Authors:  Amedeo Columbano; Grazia Chiellini; Marta Anna Kowalik
Journal:  Gene Expr       Date:  2017-06-13

2.  Non-natural phenolic amino acids Synthesis and application in peptide chemistry.

Authors:  A Hutinec; A Ziogas; A Rieker
Journal:  Amino Acids       Date:  1996-09       Impact factor: 3.520

3.  Targeting thyroid hormone receptor-beta agonists to the liver reduces cholesterol and triglycerides and improves the therapeutic index.

Authors:  Mark D Erion; Edward E Cable; Bruce R Ito; Hongjian Jiang; James M Fujitaki; Patricia D Finn; Bao-Hong Zhang; Jinzhao Hou; Serge H Boyer; Paul D van Poelje; David L Linemeyer
Journal:  Proc Natl Acad Sci U S A       Date:  2007-09-18       Impact factor: 11.205

4.  Serum paraoxonase 1 activity is decreased in thyroid dysfunction.

Authors:  F Azizi; F Raiszadeh; M Solati; A Etemadi; M Rahmani; M Arabi
Journal:  J Endocrinol Invest       Date:  2003-08       Impact factor: 4.256

5.  A case of hypothyroidism and type 2 diabetes associated with type V hyperlipoproteinemia and eruptive xanthomas.

Authors:  Jeong Rang Park; Tae Sik Jung; Jung Hwa Jung; Gyeong-Won Lee; Me Ae Kim; Ki-Jong Park; Deok Ryong Kim; Se-Ho Chang; Soon Il Chung; Jong Ryeal Hahm
Journal:  J Korean Med Sci       Date:  2005-06       Impact factor: 2.153

6.  A TRbeta-selective agonist confers resistance to diet-induced obesity.

Authors:  Beatriz S Amorim; Cintia B Ueta; Beatriz C G Freitas; Renata J Nassif; Cecília Helena de Azevedo Gouveia; Marcelo A Christoffolete; Anselmo S Moriscot; Carmen Lucia Lancelloti; Flávia Llimona; Hermes Vieira Barbeiro; Heraldo Possolo de Souza; Sergio Catanozi; Marisa Passarelli; Marcelo S Aoki; Antonio C Bianco; Miriam O Ribeiro
Journal:  J Endocrinol       Date:  2009-08-27       Impact factor: 4.286

Review 7.  Dietary protein and atherogenesis.

Authors:  C A Barth; M Pfeuffer
Journal:  Klin Wochenschr       Date:  1988-02-15

8.  Chromosome 19 open reading frame 80 is upregulated by thyroid hormone and modulates autophagy and lipid metabolism.

Authors:  Yi-Hsin Tseng; Po-Yuan Ke; Chia-Jung Liao; Sheng-Ming Wu; Hsiang-Cheng Chi; Chung-Ying Tsai; Cheng-Yi Chen; Yang-Hsiang Lin; Kwang-Huei Lin
Journal:  Autophagy       Date:  2013-11-11       Impact factor: 16.016

Review 9.  Emerging regulation and function of betatrophin.

Authors:  Yi-Hsin Tseng; Yung-Hsin Yeh; Wei-Jan Chen; Kwang-Huei Lin
Journal:  Int J Mol Sci       Date:  2014-12-18       Impact factor: 5.923

10.  A Case of Recurrent Chalazia Associated with Subclinical Hypothyroidism.

Authors:  Robbert Bipat; Dineshpersad Jiawan; Jerry R Toelsie
Journal:  Case Rep Ophthalmol       Date:  2020-06-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.